Skip to content
The Nexus
DossierENTITY

Aviv Regev

Coverage of Aviv Regev in the Nexus archive.

Earliest in view: Jun 16 · 07:00 UTCMost recent: Jun 16 · 08:30 UTC
Co-mentioned in this coverage
International Human Cell Atlas Consortiumorganization1David Altshulerperson1Eric Landerperson110x Genomicsorganization1spatial biologytopic1Vizgenorganization1Illuminaorganization1biomedical sciencetopic1frustrationtopic1
Recent coverage
  • SCIENCEJun 16 · 08:30 UTCSTAT NEWS
    STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions

    The International Human Cell Atlas Consortium is hosting a major meeting in Boston, featuring leaders like Aviv Regev and Eric Lander, as it advances toward publishing its first draft of a comprehensive human cell map. The project faces potential conflict-of-interest concerns due to its reliance on 10x Genomics' technology, which is now competing with other emerging spatial biology tools from companies like Vizgen and Illumina.

  • SCIENCEJun 16 · 07:00 UTCSCIENTIFIC AMERICAN
    Aviv Regev

    Aviv Regev, a biotech executive, discusses the current inflection point in biomedical science and the positive role of frustration.

Aviv Regev · Dossier · The Nexus